Sortilin: The mechanistic link between genes, cholesterol, and coronary artery disease

Cardiology in Review

Volumn 22, Issue 2, 2014, Pages 91-96

  Thaker, Adarsh M ^a   Frishman, William H ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

genome wide association studies; hyperlipidemia; low density lipoprotein cholesterol; SORT1; sortilin

Indexed keywords

ADAPTOR PROTEINS, VESICULAR TRANSPORT; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERLIPIDEMIAS; LIPID METABOLISM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84894215692     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0000000000000008     Document Type: Review

References (35)

1. Glueck CJ, Kwiterovich PO Jr. The lipid hypothesis. Genetic basis. Arch Surg. 1978;113:35-41.
2. Kjolby M, Andersen OM, Rreiderhoff T, et al. Sortl, encoded by the cardiovascular risk locus lpl 3.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213-223.
3. Centers for Disease Control and Prevention. High Cholesterol: Understand Your Risks. 2012. Available at: http://www.cdc.gov/cholesterol. Accessed March 15, 2012.
4. Waters DD, Rrotons C, Chiang CW, et al; Lipid Treatment Assessment Project 2 Investigators. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009;120:28-34.
5. Samani NJ, Erdmann J, Hall AS, et al; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl JMed. 2007;357:443-453.
6. Zeller T, Rlankenberg S, Diemert P. Genomewide association studies in cardiovascular disease-an update 2011. Clin Chem. 2012;58:92-103.
7. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189-197.
8. Wilier CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161-169.
9. Sandhu MS, Waterworth DM, Debenham SL, et al; Wellcome Trust Case Control Consortium. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008;371:483-491.
10. Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82:139-149.
11. Aulchenko YS, Ripatti S, Lindqvist I, et al; ENGAGE Consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41:47-55.
12. Kathiresan S, Wilier CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56-65.
13. Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet. 2009;41:35-46.
14. Samani NJ, Braund PS, Erdmann J, et al. The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med (Berl). 2008;86:1233-1241.
15. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the lpl3 cholesterol locus. Nature. 2010;466:714-719.
16. Dube JB, Johansen CT, Hegele RA. Sortilin: an unusual suspect in cholesterol metabolism: from GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. Bioessays. 2011;33:430-437.
17. Nielsen MS, Jacobsen C, Olivecrona G, et al. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999;274:8832-8836.
18. Pallesen LT, Vaegter CB. Sortilin and SorLA regulate neuronal sorting of trophic and dementia-linked proteins. Mol Neurobiol. 2012;45:379-387.
19. Petersen CM, Nielsen MS, Nykjaer A, et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem. 1997;272:3599-3605.
20. Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature. 2004;427:843-848.
21. Reitz C, Tokuhiro S, Clark LN, et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol. 2011;69:47-64.
22. He Y, Fang Z, Yu G. Sortilin-related VPS 10 domain containing receptor 1 and Alzheimer's disease-associated allelic variations preferentially exist in female or type 2 diabetes mellitus patients in southern Han Chinese. Psychogeriatrics. 2012;12:215-225.
23. Gustafsen C, Glerup S, Pallesen LT, et al. Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein. J Neurosci. 2013;33:64-71.
24. Hu F, Padukkavidana T, Vsegter CB, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron. 2010;68:654-667.
25. Klinger SC, Glerup S, Raarup MK, et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sci. 2011;124(pt 7):1095-1105.
26. Farese RV Jr, Linton MF, Young SG. Apolipoprotein B gene mutations affecting cholesterol levels. J Intern Med. 1992;231:643-652.
27. Nilsson SK, Christensen S, Raarup MK, et al. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS 1 Op domain receptor families. JBiol Chem. 2008;283:25920-25927.
28. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
29. Wilier CJ, Mohlke KL. Finding genes and variants for lipid levels after genome-wide association analysis. Curr Opin Lipidol. 2012;23:98-103.
30. Roth EM, Me Kenney JM, Hanotin C, et al. Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. NEngl JMed. 2012;367:1891-1900.
31. Blattmann P, Schuberth C, Pepperkok R, et al. RNAi-based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function. PLoS Genet. 2013;9:el003338.
32. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome lpl3.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010;208:183-189.
33. Willnow TE, Petersen CM, Nykjaer A. VPS 1 OP-domain receptors-regulators of neuronal viability and function. Nat Rev Neurosci. 2008;9:899-909.
34. Capsoni S, Amato G, Vignone D, et al. Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation. Biochem Biophys Res Commun. 2013;431:579-585.
35. McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl JMed. 2011;364:340-350.